INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2016
Net Assets |
£217m |
Net Assets per share |
576p |
Share price |
498p |
Total value of unquoted investments |
£23m |
Total number of portfolio companies |
82 |
Top Ten Holdings
Company Name |
% NAV |
Biogen |
7.7 |
Celgene |
7.0 |
Regeneron |
6.3 |
Incyte |
5.2 |
Alexion |
4.7 |
Actelion |
4.6 |
Amgen |
3.8 |
Vertex |
3.6 |
Biomarin |
3.3 |
Exelixis |
3.1 |
|
----------- |
Total |
49.3 |
Geographical Allocation |
% NAV |
US & Canada |
78 |
Europe & UK |
22 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
90 |
Unquoted |
10 |
|
----------- |
Total |
100 |
NAV % Market Cap |
% NAV |
Large Cap >USD10BN |
72 |
Small Cap <USD1BN |
23 |
Mid Cap =USD1-10BN |
5 |
|
----------- |
Total |
100 |
NAV % by Therapeutic Areas |
% NAV |
Oncology |
34 |
Orphan |
22 |
CNS |
10 |
Inflammation |
9 |
Ophthalmology |
8 |
Medtech |
1 |
Other |
16 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
12 SEPTEMBER 2016